Joanna Wiensch
Stock Analyst at Citigroup
(1.78)
# 2,117
Out of 4,667 analysts
29
Total ratings
73.68%
Success rate
13.48%
Average return
Main Sectors:
Stocks Rated by Joanna Wiensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Upgrades: Buy | $255 → $275 | $222.39 | +23.66% | 5 | Oct 1, 2024 | |
| ABT Abbott Laboratories | Maintains: Buy | $119 → $127 | $115.93 | +9.55% | 8 | Aug 22, 2024 | |
| NVRO Nevro | Downgrades: Neutral | $40 | $4.23 | +845.63% | 1 | Jan 17, 2023 | |
| DXCM DexCom | Maintains: Buy | $83 → $90 | $75.24 | +19.95% | 2 | Apr 29, 2020 | |
| COO The Cooper Companies | Maintains: Neutral | $90 → $80 | $99.08 | -19.76% | 2 | Mar 27, 2020 | |
| IRTC iRhythm Technologies | Initiates: Buy | $120 | $73.74 | +62.73% | 1 | Mar 5, 2020 | |
| PEN Penumbra | Initiates: Buy | $200 | $239.20 | -16.39% | 1 | Mar 5, 2020 | |
| GKOS Glaukos | Initiates: Sell | $40 | $141.44 | -71.72% | 1 | Mar 5, 2020 | |
| ZBH Zimmer Biomet Holdings | Initiates: Buy | $168 | $109.27 | +53.75% | 1 | Mar 5, 2020 | |
| ALC Alcon | Initiates: Neutral | $63 | $85.50 | -26.32% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $235 | $385.68 | -39.07% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $220 | $266.58 | -17.47% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $84 | $69.54 | +20.79% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $94 | $32.63 | +188.08% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $163 | $153.11 | +6.46% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $84.11 | +47.43% | 1 | Mar 5, 2020 |
Becton, Dickinson and Company
Oct 1, 2024
Upgrades: Buy
Price Target: $255 → $275
Current: $222.39
Upside: +23.66%
Abbott Laboratories
Aug 22, 2024
Maintains: Buy
Price Target: $119 → $127
Current: $115.93
Upside: +9.55%
Nevro
Jan 17, 2023
Downgrades: Neutral
Price Target: $40
Current: $4.23
Upside: +845.63%
DexCom
Apr 29, 2020
Maintains: Buy
Price Target: $83 → $90
Current: $75.24
Upside: +19.95%
The Cooper Companies
Mar 27, 2020
Maintains: Neutral
Price Target: $90 → $80
Current: $99.08
Upside: -19.76%
iRhythm Technologies
Mar 5, 2020
Initiates: Buy
Price Target: $120
Current: $73.74
Upside: +62.73%
Penumbra
Mar 5, 2020
Initiates: Buy
Price Target: $200
Current: $239.20
Upside: -16.39%
Glaukos
Mar 5, 2020
Initiates: Sell
Price Target: $40
Current: $141.44
Upside: -71.72%
Zimmer Biomet Holdings
Mar 5, 2020
Initiates: Buy
Price Target: $168
Current: $109.27
Upside: +53.75%
Alcon
Mar 5, 2020
Initiates: Neutral
Price Target: $63
Current: $85.50
Upside: -26.32%
Mar 5, 2020
Initiates: Buy
Price Target: $235
Current: $385.68
Upside: -39.07%
Mar 5, 2020
Initiates: Buy
Price Target: $220
Current: $266.58
Upside: -17.47%
Mar 5, 2020
Initiates: Buy
Price Target: $84
Current: $69.54
Upside: +20.79%
Mar 5, 2020
Initiates: Neutral
Price Target: $94
Current: $32.63
Upside: +188.08%
Mar 5, 2020
Initiates: Buy
Price Target: $163
Current: $153.11
Upside: +6.46%
Mar 5, 2020
Initiates: Buy
Price Target: $124
Current: $84.11
Upside: +47.43%